Geburtseinleitung

Bei etwa 20–25% aller Schwangerschaften wird eine Geburtseinleitung durchgeführt. Das Wissen über spezifische Zulassungsindikationen und Kontraindikationen für Einleitungsverfahren ist entscheidend, obwohl einige Verfahren auch ohne offizielle Zulassung und Kontraindikation in Betracht gezogen werden können, wenn ausreichende Evidenz vorliegt. Der folgende Beitrag stellt den leitliniengerechten Ablauf vor.

Schlüsselwörter

Geburtseinleitung - Indikation - Methoden - Medikamente - Kaiserschnitt

• Literatur

• 1 Kehl S, Hösli I, Pecks U. et al. Induction of Labour. Guideline of the DGGG, OEGGG and SGGG (S2k, AWMF Registry No. 015–088, December 2020). Geburtshilfe Frauenheilkd 2021; 81: 870-895
• 2 Saccone G, Berghella V. Induction of labor at full term in uncomplicated singleton gestations: a systematic review and metaanalysis of randomized controlled trials. Am J Obstet Gynecol 2015; 213: 629-636
• 3 Society of Maternal-Fetal Publications Committee. Electronic address pso. SMFM Statement on Elective Induction of Labor in Low-Risk Nulliparous Women at Term: the ARRIVE Trial. Am J Obstet Gynecol 2018; 216
• 4 Rosenstein MG, Cheng YW, Snowden JM. et al. The risk of stillbirth and infant death stratified by gestational age in women with gestational diabetes. Am J Obstet Gynecol 2012; 206: 309.e1-309.e7
• 5 Schwarz C, Weiss E, Loytved C. et al. [Foetal Mortality in Singleton Foetuses at and beyond Term – An Analysis of German Perinatal Data 2004–2013]. Z Geburtshilfe Neonatol 2015; 219: 81-85
• 6 Morris JM, Roberts CL, Bowen JR. et al. Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet 2016; 387: 444-452
• 7 Middleton P, Shepherd E, Flenady V. et al. Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database Syst Rev 2017; (01) CD005302
• 8 Witkop CT, Neale D, Wilson LM. et al. Active compared with expectant delivery management in women with gestational diabetes: a systematic review. Obstet Gynecol 2009; 113: 206-217
• 9 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe e.V. (DGGG). Intrauterine growth restriction. Guideline of the German Society of Gynecology and Obstetrics (S2k, AWMF-Registernummer: 015/080, Oktober 2016). Accessed January 15, 2024 at: http://www.awmf.org/leitlinien/detail/ll/015–080.html
• 10 Puljic A, Kim E, Page J. et al. The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age. Am J Obstet Gynecol 2015; 212: 667.e1-667.e5
• 11 Ovadia C, Seed PT, Sklavounos A. et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet 2019; 393: 899-909
• 12 Habli M, Levine RJ, Qian C. et al. Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. Am J Obstet Gynecol 2007; 197: 406e1-406e7
• 13 Broekhuijsen K, van Baaren GJ, van Pampus MG. et al. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet 2015; 385: 2492-2501
• 14 van der Tuuk K, Koopmans CM, Groen H. et al. Impact of the HYPITAT trial on doctors’ behaviour and prevalence of eclampsia in the Netherlands. BJOG 2011; 118: 1658-1660
• 15 Koopmans CM, Bijlenga D, Groen H. et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 2009; 374: 979-988
• 16 Ram M, Berger H, Geary M. et al. Timing of Delivery in Women With Chronic Hypertension. Obstet Gynecol 2018; 132: 669-677
• 17 Boulvain M, Senat MV, Perrotin F. et al. Induction of labour versus expectant management for large-for-date fetuses: a randomised controlled trial. Lancet 2015; 385: 2600-2605
• 18 Grobman WA, Rice MM, Reddy UM. et al. Labor Induction versus Expectant Management in Low-Risk Nulliparous Women. N Engl J Med 2018; 379: 513-523
• 19 Chiossi G, D’Amico R, Tramontano AL. et al. Prevalence of uterine rupture among women with one prior low transverse cesarean and women with unscarred uterus undergoing labor induction with PGE2: A systematic review and meta-analysis. PloS One 2021; 16: e0253957
• 20 Shetty A, Burt R, Rice P. et al. Women’s perceptions, expectations and satisfaction with induced labour--a questionnaire-based study. Eur J Obstet Gynecol Reprod Biol 2005; 123: 56-61
• 21 Finucane EM, Murphy DJ, Biesty LM. et al. Membrane sweeping for induction of labour. Cochrane Database Syst Rev 2020; (02) CD000451
• 22 de Vaan MD, Ten Eikelder ML, Jozwiak M. et al. Mechanical methods for induction of labour. Cochrane Database Syst Rev 2019; (10) CD001233
• 23 Kehl S, Weiss C, Dammer U. et al. Double-balloon catheter and sequential oral misoprostol versus oral misoprostol alone for induction of labour at term: a retrospective cohort study. Eur J Obstet Gynecol Reprod Biol 2016; 204: 78-82
• 24 Ande AB, Ezeanochie CM, Olagbuji NB. Induction of labor in prolonged pregnancy with unfavorable cervix: comparison of sequential intracervical Foley catheter-intravaginal misoprostol and intravaginal misoprostol alone. Arch Gynecol Obstet 2012; 285: 967-971
• 25 Ornat L, Alonso-Ventura V, Bueno-Notivol J. et al. Misoprostol combined with cervical single or double balloon catheters versus misoprostol alone for labor induction of singleton pregnancies: a meta-analysis of randomized trials. J Matern Fetal Neonatal Med 2020; 33: 3453-3468
• 26 Gallagher LT, Gardner B, Rahman M. et al. Cervical Ripening Using Foley Balloon with or without Oxytocin: A Systematic Review and Meta-Analysis. Am J Perinat 2019; 36: 406-421
• 27 Alfirevic Z, Keeney E, Dowswell T. et al. Labour induction with prostaglandins: a systematic review and network meta-analysis. BMJ 2015; 350: h217
• 28 Boulvain M, Kelly A, Irion O. Intracervical prostaglandins for induction of labour. Cochrane Database Syst Rev 2008; (01) CD006971
• 29 Alfirevic Z, Keeney E, Dowswell T. et al. Which method is best for the induction of labour? A systematic review, network meta-analysis and cost-effectiveness analysis. Health Technol Assess 2016; 20: 1-584
• 30 ACOG Practice Bulletin No. 135: Second-trimester abortion. Obstet Gynecol [Anonym]. 2013; 121: 1394-1406
• 31 Wildschut H, Both MI, Medema S. et al. Medical methods for mid-trimester termination of pregnancy. Cochrane Database Syst Rev 2011; (01) CD005216
• 32 Ebbers S, Creemers JW, Lotgering FK. [Termination of pregnancy in the 2nd trimester: mifepriston/misoprostol preferable to sulprostone]. Ned Tijdschr Geneeskd 2009; 153: A138